Drug Shortage Report for APO-OMEPRAZOLE

Last updated on 2017-04-04 History
Report ID 674
Drug Identification Number 02245058
Brand name APO-OMEPRAZOLE
Common or Proper name OMEPRAZOLE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) OMEPRAZOLE
Strength(s) 20MG
Dosage form(s) CAPSULE (DELAYED RELEASE)
Route of administration ORAL
Packaging size 500 BTL
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-03-26
Actual start date
Estimated end date 2017-04-04
Actual end date 2017-04-03
Shortage status Resolved
Updated date 2017-04-04
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2017-04-04 French Compare
v6 2017-04-04 English Compare
v5 2017-03-27 French Compare
v4 2017-03-27 English Compare
v3 2017-03-27 English Compare
v2 2017-03-12 French Compare
v1 2017-03-12 English Compare